Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Resource and Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
Foxp3 drives oxidative phosphorylation and protection from lipotoxicity
Duncan Howie, … , Alexander G. Betz, Herman Waldmann
Duncan Howie, … , Alexander G. Betz, Herman Waldmann
Published February 9, 2017
Citation Information: JCI Insight. 2017;2(3):e89160. https://doi.org/10.1172/jci.insight.89160.
View: Text | PDF
Research Article Immunology Metabolism

Foxp3 drives oxidative phosphorylation and protection from lipotoxicity

  • Text
  • PDF
Abstract

Tregs can adopt a catabolic metabolic program with increased capacity for fatty acid oxidation–fueled oxidative phosphorylation (OXPHOS). It is unclear why this form of metabolism is favored in Tregs and, more specifically, whether this program represents an adaptation to the environment and developmental cues or is “hardwired” by Foxp3. Here we show, using metabolic analysis and an unbiased mass spectroscopy–based proteomics approach, that Foxp3 is both necessary and sufficient to program Treg-increased respiratory capacity and Tregs’ increased ability to utilize fatty acids to fuel oxidative phosphorylation. Foxp3 drives upregulation of components of all the electron transport complexes, increasing their activity and ATP generation by oxidative phosphorylation. Increased fatty acid β-oxidation also results in selective protection of Foxp3+ cells from fatty acid–induced cell death. This observation may provide novel targets for modulating Treg function or selection therapeutically.

Authors

Duncan Howie, Stephen Paul Cobbold, Elizabeth Adams, Annemieke Ten Bokum, Andra Stefania Necula, Wei Zhang, Honglei Huang, David J. Roberts, Benjamin Thomas, Svenja S. Hester, David J. Vaux, Alexander G. Betz, Herman Waldmann

×

Figure 2

mTOR inhibition and Foxp3 expression act independently to regulate OXPHOS.

Options: View larger image (or click on image) Download as PowerPoint
mTOR inhibition and Foxp3 expression act independently to regulate OXPHO...
(A) Basal and spare respiratory capacity (SRC) of EL4.cFoxp3 T cells following 4’HT, rapamycin, or combination 4’HT+rapamycin treatment for 48 hours. Results representative of 3 experiments. In all panels, boxes span 25th to 75th percentiles, whiskers represent minimum and maximum values, and horizontal line shows median. *P < 0.05 by Student’s t test. (B) Basal and SRC of activated Marilyn.foxp3hCD2 knockin CD4+ T cells (Tact). Cells were activated for 7 days with DCs and peptide before flow sorting and overnight treatment with 5 nM rapamycin. Results representative of 2 experiments. (C and D) Basal and SRC of activated Marilyn.foxp3hCD2 knockin CD4+ Foxp3+ and Foxp3– T cells. Cells were activated for 7 days with DCs and peptide in the presence of TGFβ before flow sorting for CD4 and CD2 and overnight treatment with 5 nM rapamycin. Results representative of 2 experiments. *P < 0.05 by Student’s t test.

Copyright © 2023 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts